The Tibet Autonomous Region promotes reagents for medical supplies | 'Two-vote system'!
Medical Network June 5th Following the implementation of the two-vote system for consumables in Shaanxi, Anhui, Qinghai, and Ningxia, another province has implemented medical consumables.
This time it is the Tibet Autonomous Region, which not only supplies high-value consumables, but also includes ordinary consumables and in vitro diagnostic reagents!
On June 1, the Tibet Autonomous Region Drug Purchase Service Management Center issued a <西藏自治区公立医疗卫生机构医耗材和体外诊断试剂集中采购实施方案 (试行) >Notice of Opinion, Officially Launched Consumables, Concentrated Reagent Purchase.
In the appendix to this notice, the two-vote system for consumables and reagents was clearly proposed:
In the attachment “Implementation Plan for Centralized Procurement of Medical Consumables and In Vitro Diagnostic Reagents of Public Health Institutions in the Tibet Autonomous Region”, among the seven conditions that can be registered by production companies, Article 6 clearly states that 'the two-vote system can be strictly enforced'. ' This condition.
The document also proposes to optimize the order of the purchase and sale of medical consumables and to compress the circulation, in accordance with the "Implementation of the "Two-vote System Implementation Opinions (Trial)" for the Centralized Procurement of Drugs in Public Medical Institutions (National Health Reform Office [2016] No. ) and other relevant documents spirit, to implement the 'two-vote system' within the district, that is, the production company to the circulation company to open an invoice, the circulation company to the medical organization to open an invoice; circulation group-type enterprise internal wholly-owned (holding) Transfer of medical consumables between a company or a wholly-owned (holding) subsidiary may not be considered as a vote, but an invoice is issued at most.
In the definition of the two-vote system, Tibet’s standard It is a commercial company established by a production company that only sells the company's products, and it is authorized by the production companies of overseas products (foreign and Hong Kong, Macao, and Taiwan products). proxy (It is limited to one domestic general agent in the country) It can be regarded as production enterprise , If you do not have a general agent in China, you only accept the declaration of one agent.
When submitting materials, both the production company and the distribution company must submit the original "Strict Implementation of the "Two-Ticket System" Commitment."
At the same time, the “Tax Autonomous Region Medical Concentrators purchase In the annex of the “Administrative Measures (Trial)”, it is also clearly stated that according to the investigation of the cost of medical consumables and the market price, in conjunction with the latest price document of the country, the bid/link price of the bid is adjusted at the right time, and publicity is announced through the procurement platform.
We severely investigated and dealt with price violations and monopolistic behaviors in accordance with the law, and counterfeited or falsely invoiced, affiliated to operations, 'take tickets' and other illegal activities. At the same time, we strengthened the daily supervision of the transaction prices of medical consumables, found violations of trading conditions, and immediately verified and notified by the Procurement Center. The leading group office made corresponding treatment.
It is reported that this centralized procurement applies to the following products:
Medical consumables: Medical tools (surgical instruments and tools), injection punctures, suture hemostasis (stitching, hemostasis, dressing protection materials), tube container filtration (piping, containers, filtration Adsorptive separations), implants (expansion materials, internal fixation materials, embolization materials, filling materials, repair materials, replacement materials), external fixation, conduction, specialty specialty (dental materials, Chinese medicine and ethnic medical materials) , Others, etc.
In Vitro Diagnostic Reagents (Classified for Clinical Use) : Pathological examinations, clinical molecular biology and cytogenetics diagnostics, clinical immunoassays, clinical biochemistry tests, clinical blood (body) fluids and blood transfusion tests, clinical microbiological examinations Wait.
Unlike other provinces, the two-vote system in Tibet involves high-value consumables, low-value consumables and in vitro diagnostic reagents. This is far more extensive than in the provinces where the two-vote system has been implemented.
Previously in October 2017, the Tibet Autonomous Region started implementing drug Two-vote system. At present, Tibet's centralized procurement implementation plan document is still a draft for soliciting opinions. The opinions are solicited until 18: 00 on June 8th. After the drug, the possibility of a smooth implementation is very great.
